Our expertise in biology, robotics, in silico analysis and bioinformatics helps cell and gene therapy pioneers advance the discovery phase of their clinical candidates.
CAR-T & Antibody Discovery
OXGENE’s proprietary CAR-T / antibody discovery platform targets challenging membrane proteins for the development of your CAR-T and other biologics.
CRISPR Libraries and Screening
Automated CRISPR screening, arrayed library production and cell line engineering services to accelerate target identification and validation.
AAV Capsid Discovery
We use proprietary technologies to identify and characterise novel AAV serotypes screened to your custom specification.
Promoter Discovery
We deploy proprietary technologies to uncover novel promoters to help maximise viral vector yield and transgene expression for your cell and gene therapies.
OXGENE provides an integrated solution that supports your entire discovery and validation workflow
Get in touch.jpg?width=50)
Are you thinking ahead to clinical manufacture?
VIEW OUR BIOMANUFACTURING SOLUTIONSOur technologies help pioneering cell and gene therapy companies achieve high-titre, scalable and cost-effective viral vector production.